Lipopolysaccharide, Salmonella typhimurium

Lipopolysaccharide (LPS) derived from Salmonella typhimurium is a potent bacterial endotoxin used extensively in scientific research to model bacterial infections and study host immune responses. LPS, also known as endotoxin, is a major component of the outer membrane of Gram-negative bacteria. In research, LPS from Salmonella typhimurium serves as a powerful tool to activate the innate immune system by interacting with Toll-like receptor 4 (TLR4) and its co-receptor, CD14, on immune cells such as macrophages and dendritic cells. This interaction triggers downstream signaling pathways, including the nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways, leading to the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). Researchers use LPS from Salmonella typhimurium to investigate various aspects of inflammation, host-pathogen interactions, and immune responses in conditions such as sepsis, inflammatory bowel disease, and autoimmune disorders. Additionally, it is employed as a standard reference material in assays for endotoxin detection, vaccine development, and immunotherapy research due to its well-characterized biological activity and reproducibility.